RXI

Serial Number 77871850
Registration 3901784
710

Registration Progress

Application Filed
Nov 13, 2009
Under Examination
Jun 15, 2010
Approved for Publication
Apr 20, 2010
Published for Opposition
Apr 20, 2010
Registered
Jan 4, 2011

Basic Information

Serial Number
77871850
Registration Number
3901784
Filing Date
November 13, 2009
Registration Date
January 4, 2011
Published for Opposition
April 20, 2010
Cancellation Date
August 6, 2021
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Aug 6, 2021

Rights Holder

PHIO PHARMACEUTICALS CORP.

03
Address
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH, MA 01752

Ownership History

RXi Pharmaceuticals Corporation

Original Applicant
03
Worcester, MA

RXi Pharmaceuticals Corporation

Owner at Publication
03
Worcester, MA

RXi Pharmaceuticals Corporation

Original Registrant
03
Worcester, MA

RNCS, INC.

New Owner After Registration #1
03
WORCESTER, MA

RXI PHARMACEUTICALS CORPORATION

New Owner After Registration #2
03
Marlborough, MA

PHIO PHARMACEUTICALS CORP.

New Owner After Registration #3
03
MARLBOROUGH, MA
USPTO Deadlines 2 active 2 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB May 20, 2010 5527 days overdue Medium Until Jun 20, 2010
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Dec 15, 2010 5318 days overdue High Until Jun 15, 2011

Application History

30 events
Date Code Type Description
Aug 6, 2021 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jan 4, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 28, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 8, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 8, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 8, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 4, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED
Dec 7, 2014 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 7, 2014 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 5, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 28, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 4, 2011 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 3, 2010 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 2, 2010 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 30, 2010 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 22, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 22, 2010 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Nov 8, 2010 EISU I TEAS STATEMENT OF USE RECEIVED
Nov 8, 2010 IUAF S USE AMENDMENT FILED
Jun 15, 2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 20, 2010 PUBO A PUBLISHED FOR OPPOSITION
Apr 20, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2010 ALIE A ASSIGNED TO LIE
Mar 13, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 22, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2010 DOCK D ASSIGNED TO EXAMINER
Nov 19, 2009 MDSM O NOTICE OF DESIGN SEARCH CODE MAILED
Nov 18, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2009 NWAP I NEW APPLICATION ENTERED

Additional Information

Design Mark
The mark consists of the letters "RXI" shown in white on a square background which has a perimeter line shown in purple, with a white line running around the interior of that purple perimeter line, with the "R" shown as an upper-case letter on a purple background, the "X" shown as a stylized letter in curved strokes suggesting a fragment of DNA on a background which is purple on the left and grey on the right, and the "I" shown as a lower-case letter on a grey background.
Color Claim
The color(s) purple, white and grey is/are claimed as a feature of the mark.
Pseudo Mark
RX INFORMATION